Biotech · Private company
Regenerative Patch Technologies, LLC
Track this companyFree. Adds Regenerative Patch Technologies, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CPCB-RPE1Phase 2 · Dry Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Surgical implantation of the CPCB-RPE1 implantPhase 2 · Dry Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)PHASE2 · RECRUITING · started Aug 1, 2025ClinicalTrials.gov NCT06557460 · fetched Nov 12, 2026
- Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMDPHASE1_PHASE2 · UNKNOWN · started Feb 16, 2016ClinicalTrials.gov NCT02590692 · fetched Nov 12, 2026